Evidence map›Paper›PMID 31540669›Full record

ArticleBiological psychiatry2020

Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS.

P Joel Ross, Wen-Bo Zhang, Rebecca S F Mok, Kirill Zaslavsky, Eric Deneault, Lia D'Abate, Deivid C Rodrigues, Ryan K C Yuen, Muhammad Faheem, Marat Mufteev and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Biological psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Mental health dished up-the use of iPSC models in neuropsychiatric research.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-FunctionThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

P Joel RossDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Wen-Bo ZhangNeurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Rebecca S F MokDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Kirill ZaslavskyDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Eric DeneaultGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Lia D'AbateGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Deivid C RodriguesDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ryan K C YuenGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Muhammad FaheemGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Marat MufteevDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Alina PieknaDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Wei WeiDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Peter PasceriDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Rebecca J LandaCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, Maryland; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Andras NagyInstitute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; Lunenfeld-Tenenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Balazs VargaLunenfeld-Tenenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Michael W SalterNeurosciences and Mental Health Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Physiology, University of Toronto, Toronto, Ontario, Canada.
Stephen W SchererGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada; McLaughlin Centre, University of Toronto, Toronto, Ontario, Canada.
James EllisDevelopmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. Electronic address: jellis@sickkids.ca.
Hospital for Sick Children · CAUniversity of Toronto · CAMount Sinai Hospital · CAKennedy Krieger Institute · US

Funding

Autism: Social And Communication Predictors in SiblingsR01MH059630 · NIMH · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI LANDA, REBECCA JEAN · 2001 to 2016
$10.7M
Patient iPS cells with Copy Number Variations to Model Nuropsychiatric DsordersR33MH087908 · NIMH · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI ELLIS, JAMES RYALL · 2011 to 2012
$685k
CIHR EPS-129129CIHR MOP-102649CIHR MOP-133423NIMH NIH HHS R01 MH059630NIMH NIH HHS R33 MH087908
6 · The paper itself

Abstract

backgroundThe Xp22.11 locus that encompasses PTCHD1, DDX53, and the long noncoding RNA PTCHD1-AS is frequently disrupted in male subjects with autism spectrum disorder (ASD), but the functional consequences of these genetic risk factors for ASD are unknown.

methodsTo evaluate the functional consequences of PTCHD1 locus deletions, we generated induced pluripotent stem cells (iPSCs) from unaffected control subjects and 3 subjects with ASD with microdeletions affecting PTCHD1-AS/PTCHD1, PTCHD1-AS/DDX53, or PTCHD1-AS alone. Function of iPSC-derived cortical neurons was assessed using molecular approaches and electrophysiology. We also compiled novel and known genetic variants of the PTCHD1 locus to explore the roles of PTCHD1 and PTCHD1-AS in genetic risk for ASD and other neurodevelopmental disorders. Finally, genome editing was used to explore the functional consequences of deleting a single conserved exon of PTCHD1-AS.

resultsiPSC-derived neurons from subjects with ASD exhibited reduced miniature excitatory postsynaptic current frequency and N-methyl-D-aspartate receptor hypofunction. We found that 35 ASD-associated deletions mapping to the PTCHD1 locus disrupted exons of PTCHD1-AS. We also found a novel ASD-associated deletion of PTCHD1-AS exon 3 and showed that exon 3 loss altered PTCHD1-AS splicing without affecting expression of the neighboring PTCHD1 coding gene. Finally, targeted disruption of PTCHD1-AS exon 3 recapitulated diminished miniature excitatory postsynaptic current frequency, supporting a role for the long noncoding RNA in the etiology of ASD.

conclusionsOur genetic findings provide strong evidence that PTCHD1-AS deletions are risk factors for ASD, and human iPSC-derived neurons implicate these deletions in the neurophysiology of excitatory synapses and in ASD-associated synaptic impairment.

Indexed as

Autism Spectrum DisorderAutistic DisorderInduced Pluripotent Stem CellsHumansMaleMembrane ProteinsNeuronsSynapsesMembrane ProteinsPTCHD1 protein, humanAutism spectrum disorderExcitatory synapsesGeneticsInduced pluripotent stem cellsLong noncoding RNANeurons

Identifiers

PMID31540669
PMCPMC6948145
OpenAlexW2964869621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.